LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-10-28
Case ID: NM_000314.8_c.105G_T_20261028_134249
Framework: ACMG/AMP 2015
Variant classification summary

NM_000314.8:c.105G>T

PTEN  · NP_000305.3:p.(Met35Ile)  · NM_000314.8
GRCh37: chr10:89653807 G>T  ·  GRCh38: chr10:87894050 G>T
Gene: PTEN Transcript: NM_000314.8
Final call
VUS
PM1 moderate PM2 supporting PP3 supporting
All criteria require review: For research and educational purposes only.
Gene
PTEN
Transcript
NM_000314.8
Protein
NP_000305.3:p.(Met35Ile)
gnomAD AF
0.0 (v4.1)
ClinVar
Likely pathogenic
OncoKB
Likely Oncogenic
Interpretation summary
Generated evidence synthesis
1
PM1 moderate: p.Met35Ile lies in a reported statistically significant PTEN mutational hotspot.
2
PM2 supporting: the variant is absent from gnomAD v2.1 and has allele frequency 0.0 in gnomAD v4.1.
3
PP3 supporting: the REVEL score is 0.947, exceeding the PTEN VCEP threshold of 0.7.
Final determination: Under the PTEN Expert Panel Version 3.2 framework, PM1 moderate plus PM2 and PP3 supporting does not meet any pathogenic or benign rule, so the result is VUS.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 N/A Not applicable: c.105G>T produces missense p.Met35Ile, whereas the PTEN PVS1 decision tree covers null, splice-site, copy-number, and initiation-codon variants.
cspec vcep_pvs1_decisiontree_pten
PS1 Not assessed Not assessed: Met35Arg and Met35Thr are alternate changes at residue 35, but neither is the identical pathogenic Met35Ile change required by PS1.
cspec vcep_mmc2 clinvar
PS2 Not assessed Not assessed: no proband-level de novo finding, confirmed maternity and paternity, disease status, or family-history data are available.
cspec
PS3 Not met Not met: Table S2 reports high-confidence Cum_score -0.876619465 for M35I, above the PTEN PS3_Moderate threshold of ≤ -1.11.
vcep_mmc2 PMID:29706350
PS4 Not assessed Not assessed: no variant-specific case-control counts, odds ratio, confidence interval, or PTEN phenotype-specificity score is available for c.105G>T.
cspec
PM1 Met Met: PTEN M35 is reported in a statistically significant hotspot, satisfying the VCEP PM1 hotspot path despite lying outside listed catalytic motifs.
cspec
PM2 Met Met at supporting strength: gnomAD v4.1 AF is 0.0 (0/1,612,312 alleles), below the <0.00001 PM2 threshold, and the variant is absent from gnomAD v2.1.
cspec gnomad_v2 gnomad_v4
PM3 N/A Not applicable: the PTEN VCEP explicitly designates PM3 as not applicable to PTEN.
cspec
PM4 N/A Not applicable: p.Met35Ile is a missense substitution with no protein-length change, while PTEN PM4 is limited to in-frame indels and stop-loss variants.
cspec
PM5 Not assessed Not assessed: Met35Arg is pathogenic at the same residue, but the required BLOSUM62 comparison for Met35Ile is unavailable.
cspec vcep_mmc2 PMID:21828076 PMID:25875300
PM6 Not assessed Not assessed: no presumed de novo observations, proband disease status, or family-history information are available for the PM6 requirements.
cspec
PP1 Not assessed Not assessed: no affected relatives, co-segregation observations, or meioses are documented against the PTEN VCEP thresholds of 3, 5, or 7.
cspec
PP2 Not assessed Not assessed: the evidence does not establish both VCEP PP2 requirements—low benign missense variation and a common missense disease mechanism.
cspec
PP3 Met Met: REVEL score 0.947 exceeds the PTEN VCEP missense PP3 threshold of >0.7.
cspec revel
PP4 N/A Not applicable: the PTEN VCEP incorporates phenotype specificity into PS4 Use 2 instead of applying PP4.
cspec
PP5 N/A Not applicable: the PTEN VCEP states that PP5 is not for use under the VCEP Review Committee recommendation.
cspec
BA1 Not met Not met: gnomAD v4.1 total allele frequency is 0.0 (0/1,612,312 alleles), below the >0.00056 BA1 threshold.
cspec gnomad_v2 gnomad_v4
BS1 Not met Not met: gnomAD v4.1 allele frequency is 0.0, below the PTEN VCEP BS1 supporting interval beginning at 0.0000043.
cspec gnomad_v2 gnomad_v4
BS2 Not met Not met: gnomAD v4.1 reports 0 homozygotes, and no qualifying healthy or PHTS-unaffected homozygous observation is available.
cspec gnomad_v4
BS3 Not met Not met: Table S2 reports high-confidence Cum_score -0.876619465 for M35I, below the PTEN BS3_Supporting requirement of phosphatase activity >0.
vcep_mmc2 PMID:29706350
BS4 Not assessed Not assessed: no affected family members with negative variant testing are documented in one family or across two families.
cspec
BP1 N/A Not applicable: the PTEN VCEP explicitly marks BP1 as Not Applicable.
cspec
BP2 Not assessed Not assessed: no documented trans observation or three qualifying cis/phase-unknown observations with different pathogenic PTEN variants are available.
cspec
BP3 N/A Not applicable: the PTEN VCEP specification explicitly marks BP3 as Not Applicable for this framework.
cspec
BP4 Not met Not met: REVEL score 0.947 is above, not below, the PTEN VCEP missense BP4 threshold of <0.5.
cspec revel
BP5 Not assessed Not assessed: no two qualifying cases with a highly penetrant alternate diagnosis and non-overlapping PTEN history are documented for c.105G>T.
cspec
BP6 N/A Not applicable: the PTEN VCEP states that BP6 is not for use under the VCEP Review Committee recommendation.
cspec
BP7 N/A Not applicable: the variant is missense and exonic, whereas PTEN BP7 covers only synonymous or intronic variants at or beyond +7/-21.
cspec
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.